PEGS Exclusive Challenge

Insights Platform

A single platform for antibody discovery.

  • Bring together all your experimental data, leverage curated open-source in-silico predictors & Apoha's advanced analytical suite.
  • Replace fragmented workflows and manual interpretation with a single, cohesive view of molecular behavior.
  • Quickly identify risks, uncover hidden trends, and make confident go/no-go decisions early in development.
Boehringer Ingelheim
Mythic Therapeutics
University of Leeds
Boehringer Ingelheim
Mythic Therapeutics
Apoha
University of Leeds

Trusted by leading players in the pharmaceutical industry and academia.

How It Works

Build. Scale. Break through.

Go from design to discovery in 5 easy steps.

1

Start

Start a new project - upload and encrypt your sequence data and existing experimental assay results.

2

Prompt & Predict

Choose from the curated in-silico predictors to flag high-risk molecules, automatically filtering out unstable or aggregation prone candidates.

3

Analyse

Analyse the remaining candidates with Apoha's automated analysis suite - visualised, ranked & compared across assays. Intuitive exploration of molecular data, trends, and comparisons through dynamic plots and dashboards.

4

Get Novel Insights

Send your most promising candidates to the Liquid Brain to receive novel high-dimensional thermodynamic fingerprints that reveal molecular behaviours beyond the reach of conventional assays. Merge Liquid Brain insights with prior results.

5

Report, Export & Collaborate

Create ready-to-share summaries and data exports for internal reviews and documentation. Share your project with your team.

Product Demo

Delivering the insights that count

All your experimental data. Curated open-source in-silico predictors & Apoha's advanced data analysis suite. In a single, secure & intuitive environment.

Video will be embedded here
Built for Confidence and Speed

Key Features

Unified data environment

Centralizes experimental developability data across assays, formats, and programs in one secure workspace. End to end encryption of sequence data: Sequence data is encrypted at source and completely private and securely accessed only by users.

LLM based analysis & visualization

Converts raw assay outputs into standardized, interpretable insights integrated with secure LLM service for enhanced analysis capabilities.

Curated open-source predictors

Integrates validated, industry standard in-silico models for biophysical property prediction selected and maintained by Apoha's experts.

Cross-assay comparability

Harmonizes results from diverse experiments to enable molecule-to-molecule and assay-to-assay comparison.

Workflow pipelines

Guides users through chained steps—from data upload to prediction, filtering, and reporting—creating a seamless, end-to-end experience.

Dashboard & executive summary views

Provides high-level summaries for program leads and decision-makers, turning data into actionable insight.

Your Data, Secured By Us

Own all of your data, protected by one password, encrypted end-to-end.

Secure Cloud

End to end encryption with enterprise-grade security.

Privacy

Only you have access to your data, each computation is isolated and secure.

Pricing

Start using today for free. Pay as you go, only for what you need.

Basic (Free)

Get the essentials to analyse your antibody candidates.

  • # of sequences allowed for in-silico predictors: 1000/month
  • # of database searches allowed: 100/month
Sign up

Enterprise

Create the plan that fits your exact needs. Speak with our team for more.

Get in touch
nimish.png

Apoha’s Insights Platform puts state-of-the-art models in the hands of experimentalists. As a scientist, what I value is that Apoha’s Insights Platform puts state-of-the-art models in the hands of experimentalists. We analyse a larger volume of assay data in one encrypted environment, reproduce results quickly, and move to go/no-go decisions earlier with stronger evidence. When we bring in Liquid Brain data, the platform becomes even more informative, revealing patterns faster and making our candidate prioritization more confident.

Dr Nimish Gera

Scientific Co-Founder, VP

Mythic Therapeutics

Get in touch with one of our team to learn more!

Contact Us